13F Holdings
中文EN

XTXXF Adastra Holdings Ltd. IFRS Annual reports only

Pharmaceutical Preparations · OTC · SEC CIK 1891512 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2022-12-31 (FY2022), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY136.2%
TTM net income YoY-55.7%
TTM EPS YoY-40.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin46.0%
Operating margin-6.0%
Net margin-32.2%
FCF margin5.2%
EBITDA margin-2.2%

Returns

ROE-21.1%
ROA-14.1%
ROIC (approx.)-3.3%
Asset turnover0.44x

Leverage & solvency

Liabilities / assets42.7%
Debt / equity0.00x
Current ratio0.71x
Interest coverage-2.33x

Cash quality & payout

Operating cash flow / net income-0.31x
Accruals ratio-18.5%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2022*2022-12-31FY2021*2021-12-31FY2020*2020-12-31
Income statement
Revenue13.30M5.63M2.50M
Cost of revenue7.18M3.68M1.71M
Gross profit6.11M1.94M785,581
R&D expense089,268181,750
Operating income-799,996-2.39M-7.17M
Interest expense343,918276,597399,248
Pretax income-4.34M-2.76M-7.62M
Income tax-56,000-15,0000
Net income-4.28M-2.75M-7.62M
EBITDA-298,632-2.12M-7.07M
EPS (basic)-0.07-0.05-0.19
EPS (diluted)-0.07-0.05-0.19
Weighted avg. shares (diluted)59.23M50.23M39.70M
Balance sheet
Cash & equivalents1.01M744,5411.15M
Receivables3.56M1.50M972,680
Inventory4.01M1.83M1.42M
Current assets9.00M4.22M3.70M
PP&E, netmay include right-of-use assets (IFRS)9.73M9.77M10.04M
Goodwill9.44M11.11M0
Intangibles3.13M3.54M0
Total assets31.80M28.76M13.74M
Current liabilities12.66M5.34M3.59M
Total liabilities13.57M6.38M3.65M
Shareholders' equity18.23M22.37M10.09M
Shares outstanding55.97M65.97M—
Cash flow statement
Operating cash flow1.32M-1.05M-2.81M
Capital expenditure625,037581,0791.83M
Free cash flow694,074-1.64M-4.63M
Investing cash flow-1.03M-262,811-1.82M
Financing cash flow-22,548915,9843.40M
Depreciation & amortization501,364272,61692,700
Stock-based compensation138,713890,5235.33M

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.